Penumbra Inc Stock
€236.00
Your prediction
Financial data and news for Penumbra
sharewise wants to provide you with the best news and tools for Penumbra, so we directly link to the best financial data sources.
Financials
News

3 Mid-Cap Medical Stocks Outperforming the Market
While major market indexes like the S&P 500 have struggled to gain traction in 2025 and remain in the red YTD, certain pockets of the market are showing impressive strength. Several medical and

Penumbra (PEN) Q2 Revenue Jumps 13%
Penumbra (NYSE:PEN), a medical device innovator focused on clot removal and vascular care, reported its second quarter 2025 results on July 29, 2025. The company delivered $339.5 million in GAAP